GlaxoSmithKline Inc.
100 Milverton Drive Suite 800, Mississauga, Ontario, L5R 4H1, CA (adresse du fournisseur telle que publiée dans les avis d'adjudication)
Contrats remportés
44
Valeur totale adjugée
$311,960,187
Première adjudication (dans les données)
2012-02-24
Dernière adjudication
2026-04-01
Contrats provinciaux et municipaux remportés
À partir des données ouvertes du Québec (SEAO), de la Ville de Toronto et de la Ville de Vancouver, jumelées par nom exact de fournisseur. Attributaires seulement. À propos de ces sources
| Date | Acheteur | Contrat | Soumissions | Valeur |
|---|---|---|---|---|
| 2026-07-23 | Centre d'acquisitions gouvernementales (Québec) | Appel d'offres Partiel Médicaments | 35 | $2,709 |
| 2026-06-17 | Centre d'acquisitions gouvernementales (Québec) | Appel d'offres Partiel Médicaments | 36 | $14,692 |
| 2026-06-03 | Centre d'acquisitions gouvernementales (Québec) | Appel d'offres Partiel Médicaments | 28 | $17,816 |
Principaux ministères acheteurs
- Public Services and Procurement Canada44 · $311,960,187
Principales catégories
Autres fournisseurs en Drugs and Biologicals
Historique d'adjudication
| Date | Titre | Ministère | Valeur | Soumissions |
|---|---|---|---|---|
| 2026-04-01 | Hepatitis B Vaccines GSK | Public Services and Procurement Canada | $9,462,827 | Inconnu |
| 2026-03-30 | Contract (GSK) - Supply Pertussis-containing vaccines | Public Services and Procurement Canada | $121,627 | Inconnu |
| 2024-06-28 | Amendment 003 Relenza | Public Services and Procurement Canada | $529,596 | Inconnu |
| 2024-03-25 | MMR, MMRV and Varicella vaccins | Public Services and Procurement Canada | $22,887,939 | Inconnu |
| 2023-01-25 | Amend 002 Meningococcal C and Quadrivalent Vaccines - GSK | Public Services and Procurement Canada | $2,335,884 | Inconnu |
| 2022-07-25 | BRANDED DRUGS-PHARMACEUTICALS | Public Services and Procurement Canada | $258,437 | Inconnu |
| 2022-03-07 | Amend 004 - Hepatitis B Adult and Pediatric Vaccine - GlaxoSmithKline Inc. | Public Services and Procurement Canada | $8,257,622 | Inconnu |
| 2022-03-04 | Amend 003 - Hepatitis A Adult and Pediatric - GlaxoSmithKline Inc. | Public Services and Procurement Canada | $1,311,092 | Inconnu |
| 2022-03-03 | Amend 006 - Hepatitis A and B Adult and Pediatric - GlaxoSmithKline Inc. | Public Services and Procurement Canada | $3,752,073 | Inconnu |
| 2022-01-06 | Drugs and Biologicals | Public Services and Procurement Canada | $1,811,160 | Inconnu |
| 2021-02-10 | Rotavirus vaccine | Public Services and Procurement Canada | $26,766,794 | Inconnu |
| 2021-01-05 | Amend 012 - PERTUSSIS VACCINES - GlaxoSmithKline Inc. | Public Services and Procurement Canada | $206,931 | Inconnu |
| 2020-04-24 | Drugs and Biologicals | Public Services and Procurement Canada | $1,095,228 | Inconnu |
| 2019-08-27 | Relenza | Public Services and Procurement Canada | $6,535,020 | Inconnu |
| 2019-08-01 | Drugs and Biologicals | Public Services and Procurement Canada | $623,935 | Inconnu |
| 2019-03-25 | Infanrix-hexa | Public Services and Procurement Canada | $49,746,079 | Inconnu |
| 2019-02-12 | Drugs and Biologicals | Public Services and Procurement Canada | $1,626,943 | Inconnu |
| 2018-06-01 | HUMAN PAPILLOMA VIRUS VACCINE | Public Services and Procurement Canada | $3,054,900 | Inconnu |
| 2018-03-28 | Pneumococcal Conjugate Vaccine | Public Services and Procurement Canada | $13,167,000 | Inconnu |
| 2018-02-16 | MMR/MMRV/Varicella | Public Services and Procurement Canada | $18,786,733 | Inconnu |
| 2018-01-02 | Hepatitis B Adult and Pediatric | Public Services and Procurement Canada | $7,348,371 | Inconnu |
| 2017-12-19 | Hepatitis A Adult and Pediatric | Public Services and Procurement Canada | $1,438,385 | Inconnu |
| 2017-05-04 | Drugs and Biologicals | Public Services and Procurement Canada | $3,416,512 | Inconnu |
| 2017-03-31 | Drugs and Biologicals | Public Services and Procurement Canada | $140,575 | Inconnu |
| 2017-01-30 | Drugs and Biologicals | Public Services and Procurement Canada | $1,311,040 | Inconnu |
| 2017-01-18 | Drugs and Biologicals | Public Services and Procurement Canada | $411,138 | Inconnu |
| 2016-08-24 | BRAND DRUGS-PHARMACEUTICALS | Public Services and Procurement Canada | $766,656 | Inconnu |
| 2016-01-28 | Meningococcal C Vaccine | Public Services and Procurement Canada | $3,603,237 | Inconnu |
| 2016-01-12 | Hepatitis A&B | Public Services and Procurement Canada | $363,766 | Inconnu |
| 2015-10-23 | Drugs and Biologicals | Public Services and Procurement Canada | $46,934,377 | Inconnu |
| 2015-02-26 | Hepatitis A Adult and Pediatrics | Public Services and Procurement Canada | $510,955 | Inconnu |
| 2015-02-20 | Hepatitis B Adult and Pediatrics | Public Services and Procurement Canada | $2,723,839 | Inconnu |
| 2015-01-27 | Rotavirus Vaccine | Public Services and Procurement Canada | $14,611,003 | Inconnu |
| 2014-03-27 | Combined MMR and Varicella Vaccine | Public Services and Procurement Canada | $14,524,986 | Inconnu |
| 2014-03-27 | Varicella Vaccine | Public Services and Procurement Canada | $5,981,262 | Inconnu |
| 2014-03-26 | Measles, Mumps and Rubella Vaccine | Public Services and Procurement Canada | $2,109,860 | Inconnu |
| 2014-02-05 | Drugs and Biologicals | Public Services and Procurement Canada | $12,216,600 | Inconnu |
| 2013-12-14 | Vials of Raxibacumab 50MG/ml | Public Services and Procurement Canada | $188,640 | Inconnu |
| 2013-06-22 | Single source pharmaceuticals | Public Services and Procurement Canada | $1,356,925 | Inconnu |
| 2012-12-18 | Hepatitis A&B | Public Services and Procurement Canada | $368,562 | Inconnu |
| 2012-03-27 | PERTUSSIS-CONTAINING VACCINES | Public Services and Procurement Canada | $14,708,563 | Inconnu |
| 2012-03-23 | Drugs and Biologicals | Public Services and Procurement Canada | $2,237,735 | Inconnu |
| 2012-03-20 | Drugs and Biologicals | Public Services and Procurement Canada | $494,241 | Inconnu |
| 2012-02-24 | Drugs and Biologicals | Public Services and Procurement Canada | $1,855,140 | Inconnu |
Contrats divulgués proactivement (plus de 10 000 $)
23 contrat(s) · $76,236,934 · 2004-06-10 – 2026-03-10. Déclarés par les ministères fédéraux ; jumelés à cette entreprise par nom de fournisseur (peut être incomplet). Les nombres de soumissions n'apparaissent que là où le ministère les a déclarés.
| Date | Description | Ministère | Valeur | Soumissions |
|---|---|---|---|---|
| 2026-03-10 | Pharmaceutical and other medicinal products | Public Health Agency of Canada | $685,797 | 1 |
| 2023-06-29 | Pharmaceutical and other medicinal products | Health Canada | $13,038 | 0 |
| 2023-06-29 | Pharmaceutical and other medicinal products | Health Canada | $26,076 | 1 |
| 2022-06-28 | Pharmaceutical and other medicinal products | Health Canada | $11,890 | 1 |
| 2020-09-01 | Pharmaceutical and other medicinal products | Health Canada | $14,001 | Inconnu |
| 2020-09-01 | Pharmaceutical and other medicinal products | Health Canada | $23,866 | Inconnu |
| 2020-08-29 | Pharmaceutical and other medicinal products | Health Canada | $11,286 | Inconnu |
| 2019-10-02 | Pharmaceutical and other medicinal products | Public Health Agency of Canada | $6,373,928 | Inconnu |
| 2019-05-08 | Pharmaceutical and other medicinal products | Health Canada | $108,085 | Inconnu |
| 2019-04-01 | Pharmaceutical and other medicinal products | Health Canada | $11,933 | Inconnu |
| 2018-04-01 | Pharmaceutical and other medicinal products | Health Canada | $11,933 | Inconnu |
| 2018-04-01 | Pharmaceutical and other medicinal products | Health Canada | $11,286 | Inconnu |
| 2017-05-24 | Pharmaceutical and other medicinal products | Health Canada | $19,467 | Inconnu |
| 2011-02-18 | DRUGS AND BIOLOGICALS | National Defence | $730,656 | Inconnu |
| 2010-08-24 | Drugs and Biologicals | National Defence | $167,442 | Inconnu |
| 2010-03-09 | Employee relocation outside Canada and/or return | Global Affairs Canada | $120,240 | Inconnu |
| 2010-01-21 | Employee relocation outside Canada and/or return | Global Affairs Canada | $35,000 | Inconnu |
| 2010-01-19 | Drugs and Biologicals | National Defence | $228,076 | Inconnu |
| 2009-12-31 | Research contracts (specify) | Public Health Agency of Canada | $53,103,659 | Inconnu |
| 2009-05-04 | Drugs and Biologicals | National Defence | $11,400,000 | Inconnu |
| 2009-01-22 | Drugs and Biologicals | National Defence | $2,253,300 | Inconnu |
| 2007-05-10 | Drugs and Biologicals | National Defence | $749,976 | Inconnu |
| 2004-06-10 | Drugs and Biologicals | National Defence | $126,000 | Inconnu |
Source : Publication proactive – contrats de plus de 10 000 $ (ouvert.canada.ca), Secrétariat du Conseil du Trésor du Canada, Licence du gouvernement ouvert – Canada.
Source : avis d'adjudication AchatsCanada, gouvernement du Canada, Licence du gouvernement ouvert – Canada. Seuls les fournisseurs gagnants sont publiés ; la liste complète des soumissionnaires n'est pas disponible. Non affilié au gouvernement du Canada.